UK markets close in 5 hours 48 minutes
  • FTSE 100

    +56.33 (+0.78%)
  • FTSE 250

    +219.45 (+1.15%)
  • AIM

    +7.76 (+0.87%)

    +0.0002 (+0.02%)

    +0.0024 (+0.20%)

    -70.47 (-0.40%)
  • CMC Crypto 200

    +13.50 (+2.98%)
  • S&P 500

    +116.01 (+3.06%)
  • DOW

    +823.28 (+2.68%)

    -0.27 (-0.25%)

    +9.70 (+0.53%)
  • NIKKEI 225

    +379.30 (+1.43%)

    +510.46 (+2.35%)
  • DAX

    +157.69 (+1.20%)
  • CAC 40

    +36.07 (+0.59%)

The Professional Acne Medication Market size was valued at USD 2.80 billion in 2021 and is predicted to reach USD 5.45 billion by 2030 with a CAGR of 7.2% from 2022-2030.

·5-min read

Market Definition: The Professional Acne Medication Market size was valued at USD 2. 80 billion in 2021 and is predicted to reach USD 5. 45 billion by 2030 with a CAGR of 7.

New York, June 15, 2022 (GLOBE NEWSWIRE) -- announces the release of the report "Professional Acne Medication Market by Distribution Channel, by Acne Type, Therapeutic Class, by Formulation : Global Opportunity Analysis and Industry Forecast, 2022-2030" -
2% from 2022-2030. Acne is one of the most common skin conditions caused due to dead skin cells, oil excreted from the skin, and clogged hair follicles. It is characterized by whiteheads, blackheads, pimples, and cysts. It affects millions of youngsters across the world. Also, body parts that are mostly affected by acne are face, shoulders, and upper part of the chest and back. Acne treatment is carried out largely by drying out the skin, making it a less inviting place for acne-causing and acne-promoting microbes to flourish. It is done either by medication or therapeutically.

Market Dynamics and Trends

The demand for professional acne medication is increasing due to increase in prevalence of acne diseases. Also, factors such as, rising teenage population, unhealthy urban lifestyle, and changes in hormone levels are expected to propel the growth of the market during the forecast period. Moreover, desire to have beautiful and aesthetic look, especially in youth is contributing towards the growth of the market. In addition, rising levels of pollution is another factor that is resulting into skin problems and in turn accelerating the demand for acne treatments in the market.
However, presence of alternative treatments and side-effects such as skin irritation, dry skin, and skin redness due to the utilization of acne medications are the factors restraining the growth of market during the forecast period. On the other hand, high market potential in untapped emerging economies and development of effective medications with lesser side effects are expected to provide lucrative growth opportunities for the market growth.

Market Segmentations and Scope of the Study:

The professional acne market has been segmented based on distribution channel, acne type, therapeutic class, formulation, and geography. Based on distribution channel, the market is bifurcated into med spa, aestheticians, dermatologist, and other professional channels. Based on acne type, the market is bifurcated into non-inflammatory acne and inflammatory acne. Based on therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. The retinoids segment is further classified into topical retinoid & combination retinoid, and oral retinoid (isoretinion). The antibiotics segment is further classified into topical antibiotic & combination antibiotics, and oral antibiotics. Based on formulation, the market is divided into topical medications and oral medications. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America region holds the lion share of professional acne medication market and is expected to continue dominating the market during the forecast period. This is attributed to factors such as surge in use of skin care products and rising prevalence of this condition in this region. Also, increasing awareness on new drugs as well as presence of many more drugs in the pipeline of pharma companies, such as Johnson & Johnson, Pfizer Inc., and Bausch Health Companies Inc. are expected to boost the demand for such products in the coming years.
Asia Pacific, on the other hand is expected to show a steady rise in the professional acne medication market due to high demand for acne therapeutics, and surge in healthcare expenditure as well as growth in awareness related to new developed therapeutics that can replace conventional acne treatment in this region. Furthermore, presence of major players such as The Derma Co., Skin Kraft, Soul Tree, and Plum Goodness boost the market growth in this region.

Competitive Landscape

The market comprises of various players such as are Almirall SA., Bausch Health Companies Inc., Johnson & Johnson, GlaxoSmithKline Plc (GSK), Galderma S.A., Mayne Pharma Group Limited, Mylan N.V., Sun Pharmaceutical Industries Limited, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These manufacturers are actively indulging in R&D initiatives, product & technology innovations, and industrial collaborations to enhance their product and increase their growth and geographical reach. For instance, in June 2021, Almirall S.A. has received United States Food and Drug Administration (FDA) approval to produce Seysara, a first-inclass tetracycline-derived oral antibiotic for the treatment of inflammatory lesions associated with the moderate to severe nonnodular acne vulgaris. Also, in April 2021, Teva Pharmaceutical Industries Ltd., launched strength generic version of Absorica capsules in 10-mg, 20-mg, 25-mg, 30-mg, 35-mg, and 40-mg dose. These capsules can be used for the treatment of severe recalcitrant nodular acne in non-pregnant patients of 12 years of age and above with multiple inflammatory nodules with a diameter of 5 mm or greater.


- Professional Acne Medication Market – By Distribution channels
- Med Spa
- Aestheticians
- Dermatologist
- Other Professional Channels
- Professional Acne Medication Market – By Acne Type
- Non-Inflammatory Acne
- Inflammatory Acne
- Professional Acne Medication Market – By Therapeutic Class
- Retinoids
- Topical Retinoid & Combination Retinoid
- Oral Retinoid (Isoretinion)
- Antibiotics
- Topical Antibiotic & Combination Antibiotics
- Oral Antibiotics
- Salicylic Acid
- Benzoyl Peroxide
- Others
- Professional Acne Medication Market – By Formulation
- Topical Medications
- Oral Medications
- Professional Acne Medication Market- By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Taiwan
- Vietnam
- Rest of Asia-Pacific
- RoW
- Latin America
- Middle east
- Africa
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting